Annual EBITDA
-$49.15 M
-$5.88 M-13.59%
December 31, 2024
Summary
- As of March 13, 2025, TARA annual EBITDA is -$49.15 million, with the most recent change of -$5.88 million (-13.59%) on December 31, 2024.
- During the last 3 years, TARA annual EBITDA has fallen by -$3.76 million (-8.27%).
- TARA annual EBITDA is now -529.05% below its all-time high of -$7.81 million, reached on December 31, 2019.
Performance
TARA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$14.31 M
-$2.07 M-16.87%
December 1, 2024
Summary
- As of March 13, 2025, TARA quarterly EBITDA is -$14.31 million, with the most recent change of -$2.07 million (-16.87%) on December 1, 2024.
- Over the past year, TARA quarterly EBITDA has dropped by -$3.38 million (-30.89%).
- TARA quarterly EBITDA is now -901.75% below its all-time high of -$1.43 million, reached on June 30, 2019.
Performance
TARA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$48.90 M
-$3.38 M-7.42%
December 1, 2024
Summary
- As of March 13, 2025, TARA TTM EBITDA is -$48.90 million, with the most recent change of -$3.38 million (-7.42%) on December 1, 2024.
- Over the past year, TARA TTM EBITDA has dropped by -$5.63 million (-13.02%).
- TARA TTM EBITDA is now -3322.97% below its all-time high of -$1.43 million, reached on June 30, 2019.
Performance
TARA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TARA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.6% | -30.9% | -13.0% |
| 3 y3 years | -8.3% | -34.8% | +31.2% |
| 5 y5 years | -529.0% | -34.8% | +31.2% |
TARA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.6% | +23.9% | -94.6% | +63.1% | -37.5% | +31.2% |
| 5 y | 5-year | -529.0% | +23.9% | -471.8% | +63.1% | -678.0% | +31.2% |
| alltime | all time | -529.0% | +23.9% | -901.8% | +63.1% | -3323.0% | +31.2% |
Protara Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$49.15 M(+13.6%) | - | - |
| Dec 2024 | - | -$14.31 M(+16.9%) | -$48.90 M(+7.4%) |
| Sep 2024 | - | -$12.25 M(+15.8%) | -$45.53 M(+3.7%) |
| Jun 2024 | - | -$10.58 M(-10.1%) | -$43.90 M(-3.3%) |
| Mar 2024 | - | -$11.77 M(+7.6%) | -$45.38 M(+4.9%) |
| Dec 2023 | -$43.27 M(-33.0%) | -$10.93 M(+2.9%) | -$43.27 M(-39.2%) |
| Sep 2023 | - | -$10.62 M(-11.9%) | -$71.12 M(+4.8%) |
| Jun 2023 | - | -$12.06 M(+24.9%) | -$67.86 M(+6.1%) |
| Mar 2023 | - | -$9.65 M(-75.1%) | -$63.93 M(-1.0%) |
| Dec 2022 | -$64.57 M | -$38.78 M(+427.5%) | -$64.57 M(+81.6%) |
| Sep 2022 | - | -$7.35 M(-9.7%) | -$35.55 M(-5.9%) |
| Jun 2022 | - | -$8.14 M(-20.9%) | -$37.80 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.29 M(+5.3%) | -$41.88 M(-6.4%) |
| Dec 2021 | -$45.40 M(+34.2%) | -$9.77 M(+1.8%) | -$44.74 M(+3.1%) |
| Sep 2021 | - | -$9.60 M(-21.5%) | -$43.40 M(+3.7%) |
| Jun 2021 | - | -$12.22 M(-7.0%) | -$41.84 M(+13.4%) |
| Mar 2021 | - | -$13.15 M(+56.1%) | -$36.88 M(+9.0%) |
| Dec 2020 | -$33.84 M(+333.1%) | -$8.43 M(+4.9%) | -$33.84 M(+21.2%) |
| Sep 2020 | - | -$8.04 M(+10.6%) | -$27.91 M(+25.6%) |
| Jun 2020 | - | -$7.27 M(-28.1%) | -$22.23 M(+35.6%) |
| Mar 2020 | - | -$10.11 M(+303.9%) | -$16.40 M(+160.8%) |
| Dec 2019 | -$7.81 M(-63.2%) | -$2.50 M(+6.3%) | -$6.29 M(+66.2%) |
| Sep 2019 | - | -$2.35 M(+64.8%) | -$3.78 M(+164.8%) |
| Jun 2019 | - | -$1.43 M | -$1.43 M |
| Dec 2018 | -$21.26 M | - | - |
FAQ
- What is Protara Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Protara Therapeutics?
- What is Protara Therapeutics annual EBITDA year-on-year change?
- What is Protara Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Protara Therapeutics?
- What is Protara Therapeutics quarterly EBITDA year-on-year change?
- What is Protara Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Protara Therapeutics?
- What is Protara Therapeutics TTM EBITDA year-on-year change?
What is Protara Therapeutics annual EBITDA?
The current annual EBITDA of TARA is -$49.15 M
What is the all time high annual EBITDA for Protara Therapeutics?
Protara Therapeutics all-time high annual EBITDA is -$7.81 M
What is Protara Therapeutics annual EBITDA year-on-year change?
Over the past year, TARA annual EBITDA has changed by -$5.88 M (-13.59%)
What is Protara Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TARA is -$14.31 M
What is the all time high quarterly EBITDA for Protara Therapeutics?
Protara Therapeutics all-time high quarterly EBITDA is -$1.43 M
What is Protara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TARA quarterly EBITDA has changed by -$3.38 M (-30.89%)
What is Protara Therapeutics TTM EBITDA?
The current TTM EBITDA of TARA is -$48.90 M
What is the all time high TTM EBITDA for Protara Therapeutics?
Protara Therapeutics all-time high TTM EBITDA is -$1.43 M
What is Protara Therapeutics TTM EBITDA year-on-year change?
Over the past year, TARA TTM EBITDA has changed by -$5.63 M (-13.02%)